FDA then takes the appropriate action to address emerging issues, prevent or contain problems, and bring the animal drug industry into compliance. Routine postmarket surveillance activities and special surveys are conducted to assure that sponsors are in compliance with regulations designated to ensure data integrity and good manufacturing practices. In FY 1999, FDA will continue activities initiated in FY 1998 to ensure that industry complies with the regulations to protect animals from transmissible degenerative neurological diseases, and to minimize any potential risk that such diseases could be transmitted from animals to humans. In addition, FDA partners with other Federal and state agencies, our stakeholders, and regulated industry to develop and sponsor workshops, symposia, and publications with a focus on prevention in order to assure the public that accurate information is disseminated and that marketed animal drugs and feeds are safe and effective. Collaborative investigational contracts to identify farm management practices will also contribute to the FDA's effort to reduce the occurrence of foodborne disease.
Research is an essential element in postmarket assurance.
Research studies are necessary in order to develop methods for detecting drugs and drug residues that may be present in food products derived from animals. In addition to methods development, analytical methods development research improves the effectiveness of monitoring for antibiotic resistance patterns and provides more rapid and accurate procedures to detect and quantify chemical substances in foods. New Animal Drug Review 1. Inform and assist product sponsors. Due to new legislative approach, application processing baselines are not yet available, but will be reestablished in FY 1998 - FY 1999.